ACCESSIBILITY

24/7

Headlines

14:50

Deel strikes multi-year deal with Arsenal as tech firm enters global sport

13:57

Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or

21:53

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

15:12

Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments

Buzz

Most popular

Daily

Weekly

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

After over $390 million in funding, Believer Meats abruptly shuts down

Israel’s quantum boom: Startups hit $500 million in funding in 2025

BlackRock in talks for major investment in creative-tech firm Artlist

More news

BioCanCell

9 stories about BioCanCell

הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Anchiano Therapeutics Schedules TASE Delisting

14.03.19|Lilach Baumer

Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer

Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq

09.01.19|Lilach Baumer

The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

04.07.18|CTech

Clal Biotechnology Industries is an Israel-based life sciences investment company

Cancer Treatment Company BioCanCell Raises $22.9 Million in Private Placement

02.07.18|CTech

The company announced the issuance of 5.9 million new shares in April

CTech’s Monday Roundup of Israeli Tech News

23.04.18|CTech

Israeli satellite operator Spacecom bundled in a bid for Tel Aviv real estate. eBay Israel general manager Yuval Matalon steps down

Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares

23.04.18|Dror Reich

The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange

CTech’s Daily Israeli Tech News Roundup

23.01.18|CTech

BioCanCell raises $25 million. Israel lags behind most developed countries on the Inclusive Development Index. Activist investor Jana Partners takes stake in Teva

Pharma Company BioCanCell Raises $25 million, Plans to Go Public in the U.S.

23.01.18|Asaf Shalev

The company said it will use the funding for clinical trials of BC-819, a drug being designed to treat early stage bladder cancer

Cancer Treatment Company Negotiating $20-25 Million Capital Injection

29.10.17|Lilach Baumer

The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange